Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study

Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study Prostate Cancer and Prostatic Diseases advance online publication, September 24 2013. doi:10.1038/pcan.2013.34 Authors: A Lustman, S Nakar, A D Cohen &S Vinker
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: Tags: hydrophobic statins hydrophilic statins prevalence Source Type: research

Related Links:

The study couldn't prove cause and effect, but it found that statins, taken alone or with metformin, did seem associated with an increase in survival.
Source: WebMD Health - Category: Consumer Health News Source Type: news
FRIDAY, Feb. 14, 2020 -- Drugs that many men with prostate cancer might already be taking -- cholesterol-lowering statins -- may help extend their survival if they have a " high-risk " form of the disease, new research suggests. High-risk patients...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
ConclusionsStatin use alone or in combination with metformin was associated with lower all ‐cause and PCa mortality among high‐risk patients, particularly in post‐diagnostic settings; further studies are warranted.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: ORIGINAL RESEARCH Source Type: research
(Thomas Jefferson University) Statin use alone or with metformin is associated with lower prostate cancer mortality from all causes, among high-risk patients.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Prostate Cancer and Prostatic Diseases, Published online: 06 February 2020; doi:10.1038/s41391-020-0207-5Associations among statins, preventive care, and prostate cancer mortality
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: Source Type: research
Telephone intervention linked to rise in men ’s vegetable consumption but not to drop in risk of progression Related items fromOnMedica Less regular PSA screening puts men at risk NICE guidance delays hinder good diabetes care Population weight control best for cutting diabetes prevalence Starting statins not beneficial in many older adults NHS must hold CCGs accountable for poor diabetes care
Source: OnMedica Latest News - Category: UK Health Source Type: news
ConclusionMetformin and statins were not associated with BFFS or DFFS improvement in our analysis. However, the small number of patients treated with these drugs limits the reliability of the results and prospective studies are needed.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research
MONDAY, Dec. 2, 2019 -- Current statin use is inversely associated with the risk for lethal prostate cancer, according to a study published online Nov. 21 in Clinical Cancer Research. Emma H. Allott, Ph.D., from Queen's University Belfast in the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Researchers at Queen's University in Belfast suggested the cholesterol-lowering drugs could reduce swelling the prostate and avoid deadly cancer, but overall rates of cancer were unchanged.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
CONCLUSIONS: Molecular tumor classification identified PTEN and inflammation/immune activation as potential mechanisms linking statins with lower lethal prostate cancer risk. These findings support a potential causal association and could inform selection of relevant biomarkers for statin clinical trials. PMID: 31754047 [PubMed - as supplied by publisher]
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Tags: Clin Cancer Res Source Type: research
More News: Cancer | Cancer & Oncology | Cholesterol | Prostate Cancer | Statin Therapy | Study | Urology & Nephrology